Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

232
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
232

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association of hyperuricemia with valvular heart disease and the modifying effect of obesity.

The Korean journal of internal medicine·2026
Same author

Development of Virtual Reality Health Literacy: Delphi Expert Consensus Study.

Journal of medical Internet research·2026
Same author

Global population frequencies of <i>NAT2</i> star alleles observed in three large biobanks.

medRxiv : the preprint server for health sciences·2026
Same author

Quantifying the Independent and Combined Contributions of Clinical, Genetic, Proteomic, and Metabolomic Signals to ASCVD Prediction.

AMIA Joint Summits on Translational Science proceedings. AMIA Joint Summits on Translational Science·2026
Same author

Cellular immunology data enable clinical severity prediction via supervised machine learning.

iScience·2026
Same author

Decoding Choroid Plexus Pathology in Alzheimer's Disease: A Longitudinal Radiomics Approach for Prodromal Identification and Risk Stratification.

CNS neuroscience & therapeutics·2026

Related Experiment Video

Updated: Jun 5, 2025

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K

PGxQA: A Resource for Evaluating LLM Performance for Pharmacogenomic QA Tasks.

Karl Keat1, Rasika Venkatesh1, Yidi Huang1

  • 1Genomics and Computational Biology Graduate Program, University of Pennsylvania, Philadelphia, PA, USA.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing
|December 13, 2024
PubMed
Summary

Large language models (LLMs) show promise for pharmacogenetics (PGx) information delivery. However, current AI models, including GPT-4o, still provide inaccurate clinical information, hindering widespread adoption in healthcare.

More Related Videos

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

Related Experiment Videos

Last Updated: Jun 5, 2025

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform
09:30

Pre-Implantation Genetic Testing for Aneuploidy on a Semiconductor Based Next-Generation Sequencing Platform

Published on: August 17, 2022

3.0K
Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies
13:24

Integration of Wet and Dry Bench Processes Optimizes Targeted Next-generation Sequencing of Low-quality and Low-quantity Tumor Biopsies

Published on: April 11, 2016

11.8K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.1K

Area of Science:

  • Pharmacogenetics
  • Artificial Intelligence
  • Precision Medicine

Background:

  • Pharmacogenetics (PGx) is crucial for precision medicine, yet clinical implementation is slow due to limited clinician and patient education.
  • Large Language Models (LLMs) offer potential for disseminating PGx information but risk providing hazardous inaccuracies in clinical settings.

Purpose of the Study:

  • To evaluate the accuracy of LLM-based chatbots in answering pharmacogenetics questions for clinicians, patients, and researchers.
  • To quantify the performance gap of current LLMs against clinical standards for pharmacogenetics information.

Main Methods:

  • Developed automated and expert-scored tests to assess chatbot performance on pharmacogenetics queries.
  • Applied benchmark tests to evaluate state-of-the-art LLMs, including GPT-4o.

Main Results:

  • Newer LLMs like GPT-4o demonstrate improved performance over predecessors.
  • Despite advancements, current LLMs do not meet the required accuracy standards for clinical pharmacogenetics applications.

Conclusions:

  • LLMs show potential for pharmacogenetics education but require further development to ensure clinical safety and reliability.
  • The developed benchmark serves as a public resource to drive progress in clinical AI for pharmacogenetics.